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1. Introduction 
The biological  role of ATP  is not only the energy 
supply for metabol ic  processes,  but also the informat ion 
t ransmiss ion [1-3] .  The products of  ATP  hydrolys is  (ADP,  
AMP and adenosine)  are also invo lved in s ignal ing pro- 
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cesses [4,5]. These compounds  control  different, often 
opposite metabol ic  processes. Therefore,  there should be 
some cell mechan isms control l ing their  concentrat ion.  ATP  
d iphosphohydro lases  (EC 3.6.1.5), commonly  cal led 
apyrases, first descr ibed over  forty years ago [6], are the 
only ATP-hydro lyz ing  enzymes of unknown metabol ic  
function. They have been found in cells of  all invest igated 
pro- and eucariota [7 -16]  and in tumors [17]. Thei r  vast 
abundance and high enzymat ic  activity suggest that 
apyrases might  play an important  role in cell metabo l i sm 
[18,19]. 
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Apyrases (3.6.1.5) and ATPases (3.6.1.3) belong to a 
group of enzymes which hydrolyze ATP. There are sub- 
stantial differences between these enzymes, however. The 
ATPases are enzymes of a high substrate specificity, hy- 
drolyzing ATP to ADP and orthophosphate. They utilize 
the energy stored in ATP for metabolite or ion transport 
processes. On the contrary, apyrases can hydrolyze differ- 
ent di- and triphosphonucleotides. In the case of ATP 
hydrolysis, the main products of the reaction are AMP and 
two orthophosphate anions. Despite the fact that both 
ATPases and apyrases hydrolyze pyrophosphate bonds of 
ATP, their physiological role seems to be different. There 
is some evidence that apyrases participate in neurotrans- 
mission [20], blood platelet aggregation and pressure regu- 
lation [21], protein glycosylation and sugar level control 
[22], as well as regulation of membrane integrity [23]. 
Apyrases reveal ow substrate specificity. They catalyze 
the hydrolysis of both di- and triphosphate nucleotides, as 
well as thiamine pyrophosphate [ 10,11,13,24,25]. Enzymes 
from different sources differ in the ATP and ADP hydroly- 
sis rate. The ATP to ADP hydrolysis rate ratio (K~h) varies 
between one and two for most apyrases [10,11,25]. The 
optimal pH for the plant enzymes is close to 6.5 
[10,13,25,26], while for the animal apyrases it is above 7 
[10,12,15]. All apyrases are insensitive for the -SH group 
reagents [9,12,24,25,27,28], but are strongly inhibited by 
chelating agents [11,25,28-30], azides [11,15,31], ATP 
analogues [17,30,32] and some of them by HgC12 [9,15,33]. 
Similarly to ATPases, apyrases do not hydrolyze inorganic 
pyrophosphate or phosphate sters [10,12,15,25]. It was 
also found that triflupromasine inhibits some ATPases, and 
is a strong inhibitor of apyrase from wheat microsomes 
and soluble enzyme from potato tubers [16,34]. 
The aim of this paper is to summarize current knowl- 
edge on apyrases and discuss our hypothesis that the 
metabolic function of apyrase is the regulation of the cell 
and tissue nucleotide level. 
2. Structure of apyrases 
All the known ATP diphosphohydrolases (apyrases) are 
built up from a single po lypept ide  chain 
[10,13,15,19,25,28,29], and are characterized by the lack 
of free -SH groups [11,15,17,31]. The only known excep- 
tion is the 70-90 kDa enzyme from pea stem microsomes, 
breaking down into two 30-40 kDa subunits during elec- 
trophoresis under denaturing conditions (SDS PAGE) [35]. 
The molecular weight of other known plant apyrases varies 
from 40 to 51 kDa [10,25]. Apyrases from animal sources 
are similar but not identical to plant enzymes. Their molec- 
ular weight varies between 50 and 189 kDa 
[10,15,19,28,30,36-40], and some of them are known to 
be glycoproteins [30,31,37]. 
In 1990 Lin [37] cloned the gene of 100 kDa ecto- 
apyrase from rat liver (called ecto-ATPase by the author). 
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Fig. 1. Differences in localization of ecto-apyrases and P type ATPases in 
the plasma membrane. ATPase (right side of the Figure) contains everal 
transmembrane s ctions. Its ATP binding site and phosphorylation site 
are in the cytoplasm. Apyrase (left) contains a single transmembrane 
section, the large N-terminal part containing ATP binding sites is in the 
extracellular space. Its phosphorylation site in the C-terminal section is in 
the cytoplasm. Symbols used: P. the phosphorylation sites; ATP, the ATP 
binding sites, 1 -O ,  glycosylation sites. 
The protein molecule consisted of 519 amino acids in a 
single polypeptide chain. The molecular weight, calculated 
based on the amino acid sequence, was 57 388 Da, and the 
missing part corresponded to the sugar fragments. There 
were 16 asparagine residues in this enzyme sequence that 
could be glycosylated (Fig. 1). The C-terminal stretch of 
71 amino acids was located on the cytoplasmic side of the 
membrane, and contained two fragments characteristic for 
the sites of phosphorylation by cAMP dependent protein 
kinase and tyrosine kinase. The N-terminal part of the 
molecule on the extra-cytoplasmic side contained two se- 
quence fragments corresponding to the nucleotide binding 
site. Najjar et al. [19] have shown that the rat liver cells are 
able to synthesize two populations of cDNA from the same 
gene. The ecto-apyrases synthesized based on these cDNA 
sequences differ in the cytoplasmic region by 60 amino 
acids, and the shorter molecules reveal a lack of both 
phosphorylation sites. In potato tubers and wheat shoots 
two isoenzymes were found, but contrary to the liver 
apyrases, these enzymes have similar molecular weight 
and different isoelectric points [13,25]. 
3. Comparative analysis of the primary structure of 
apyrase and other proteins 
ATPases (EC 3.6.1,3) and apyrases (EC 3.6.1.5) belong 
to a group of enzymes which hydrolyze ATP. Possibly this 
is the reason why in some papers apyrases are called 
ATPases or Ca2+-ATPases [18,19,27,37,41,42]. Little is 
known about the catalytic site of apyrase. However, one 
might expect some similarities between ATPases and 
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Ap 50-64 YWYKGTTLNPDSE IA 
Ap 108-122 VFDQQFNPIQTSVQF 
Ap 158-174 TSYLWSRNGESLSEGDR 
Ap 330-346 SKDTGVSVRWLFNSQSL 
ATPase  1-57 YWYKGT T LNPDSE IADQQFNP I QT SVQ FSRNGE S LSEGDRSKDTGVSVRQLTDRMTL 
*************************************************  • + +* 
Fig. 2. Sequence alignment of P-type ATPase (PIR A34646) and liver ecto-apyrase [37] from a rat. Apyrase fragments are coded Ap, P-type ATPase 
fragment is marked ATPase. Three apyrase fragments, residues 50-64, 108-122 and 158-174 exhibit 100% identity to ATPase fragment 1-57. The fourth 
apyrase fragment 330-346 reveals 64% identity and 76% similarity. The conserved amino acids in apyrase sequence with respect to the ATPase fragments 
are marked as follows: ( * ) identity, ( + ) similarity. Groups of similar amino acids defined consistent with Serrano [48] as (M,I,L,V,F); (F,Y,W); (H,R,K); 
(D,N,E,Q); (S,T,A,G,P,C). 
apyrases in the catalytic or nucleotide binding sites. The 
active residues of the ATPase catalytic sites and the con- 
sensus sequences for ATPases are known. The heuristic 
BLAST algorithm [43] for locally optimal sequence align- 
ment at the NCBI BLAST server, as well as the Homology 
program by Biosym [44] were used to analyze the similari- 
ties between the sequence of rat liver ecto-ATPase [37] 
and sequences of ATPases and other proteins contained in 
the non-redundant sequence database. 
Comparative analysis revealed that the 57 amino acid 
long stretch of the P type ATPase (probable Ca2+-trans - 
porting ATPase from rat; PIR A34646) was the only 
ATPase fragment showing high sequence similarity to rat 
liver ecto-ATPase. Three sections of this fragment (15, 13 
and 12 amino acids) had 100% identity and a 17 amino 
acid fragment was characterized by 64% identity and 76% 
similarity (Fig. 2). This result might be expected, consider- 
ing that among the three types of ATPases [3], the P- 
ATPases seem to be the most similar to apyrases. They are 
built up from a single polypeptide chain with a molecular 
weight close to 100 kDa. The remaining F and V ATPases 
consist of several protein subunits, and their molecular 
weight exceeds ignificantly that reported for apyrases. 
We have also found 96% sequence identity between 
ecto-ATPase and the cell adhesion molecule, short form 
[45], built up from 458 amino acids. In a recent paper, 
Dhandzhugazyan d Bock have shown that the cell adhe- 
sion molecule CCAM demonstrates the (Ca 2 +- 
Mg 2÷)ATPase activity [46]. Aurivillius et al. have shown 
that the 105 kDa cell CAM (54-58 kDa polypeptide chain) 
is an 'ecto-ATPase' [47]. Lin has shown that the rat liver 
apyrase polypeptide chain is built up from 519 amino acids 
[37], apparently longer than that of CAM protein. How- 
ever, Najjar et al. [19] described the second iso-form of 
apyrase, shorter by 60 amino acids. The length of its 
polypeptide chain (460 residues) exactly corresponds to 
the rat liver CAM chain, as reported by Edlund et al. [45]. 
Since the physico-chemical and catalytic properties of the 
ecto-hydrolases of ATP are similar to those of apyrases, 
we suppose that CAM and ecto-ATPase from the rat liver 
are ecto-apyrases. 
3.1. Comparative structure analysis of catalytically impor- 
tant fragments of P-ATPases and rat liL, er ecto-apyrase 
Despite the lack of clear sequence similarity between 
apyrase and ATPases, additional sequence matching was 
performed using several catalytically important consensus 
sequences of ATPases. Serrano et al. [48] mentioned 6
highly conserved sequence motifs in plasma membrane 
H+-ATPases. Three of them, DPPRDDT (Serrano motif 
IV), MITGD (motif V) and TGDGVNDAPS or 
GDGxNDxP (motif VI), contain conserved aspartic acid 
residues and are interpreted as ATP binding sequences. We 
did not find these fragments in apyrase, and this empha- 
sizes its difference from ATPases. The analogue of the 
first fragment, Serrano motif IV, can be found between 
residues 179 and 185 as EGNRTLT, or as a fragment 
62-68 EIARYIR. The fragment resembling MITGD, Ser- 
rano motif V, was found between residues 84 and 88 as 
TIYSN, and is located in a larger fragment corresponding 
to motif V in the consensus region D. The sequence 
similarities are shown on Fig. 3. 
The third sequence fragment suggested as an ATP 
binding stretch (Serrano motif VI) is a part of consensus 
region E. We have found a limited sequence similarity 
between a 159-213 fragment of apyrase and a consenus 
region E as defined by Serrano. 
Comparison of the rat liver 'ecto-ATPase' sequences 
[37] with the Serrano fragment II and ATPase phospho- 
rylated intermediate sites, as reported by Rao et al. [49], 
Nakamoto and Slayman [50], Nelson and Taiz [51] and 
Wang et al. [52], shown on Fig. 4, revealed a relatively 
good match for the N-terminal fragment between residues 
19 and 83. This observation may suggest hat during a 
reaction catalyzed by apyrase, a phosphorylated intermedi- 
ate is formed. This is not yet confirmed by any research on 
the catalytic mechanism of apyrase. The short stretch of 
strongly conserved residues containing aspartate, CSDKT- 
GTLT, is pointed out as being the one forming the cova- 
*+_*  __  +*  + +*  +-*** ,~*  ~ _ . __  
(a) DPPRI EVAS SVKLCRQAG I RV IM I TG~)NKGTAV'A 
(b) EGNRTLTLLNVRRTDKGYYECEARNPATFNRSDP 
(c) E IARYIRSDNMSKTGPAYSGRET IYSNGSLFFQN 
Fig. 3. Superposition of the ATP binding sequence of the Serrano [48] 
consensus region D (a), matched with the ecto-apyrase [37] sequence 
fragments 179-212 (b) and 62-95 (c). Serrano motifs IV and V are 
indicated by bold lettering. Top line indicates the homology in a group of 
12 structures of ATPases with a phosphorylated intermediate asfound by 
Serrano [48]: amino acids conserved in all 12 sequences marked by (*), 
residues conserved in all but two ATPases indicated by (+), while the 
homology found in all H+-ATPases marked by ( - ) .  The groups of 
similar amino acids were defined by Serrano as follows: (M,I,L,V,F); 
(F,Y,W); (H,R,K); (D,N,E,Q); (S,T,A,G,P,C). 
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( a ) FSKGASE FSKGASE 
(b) ICSDKTGTLT  ICSDKTGTLT  
(c) C SDKTGTLT  CSDKTGTLT  
( d ) TGIKV I  DLMC P FAKGGKVGL FGGAGVGKTV 
(e) VALAVAAI  PEGLPAV I T TCLALGTRRMAKKNAIVRS LP SVE TLGCT SV I C SDKTGTLT  TNQ 
(f) QVTVDAVPPNVVEEKSVLLLAHNLPQEFQVFYWYKGTTLNPDSE IARY I RSDNI~KTGPAYSGRE 
*++** ***++ 
Fig. 4, Sequence match between apyrase and fragments described in literature as the ATPase phosphorylation sites. Wang et al. [52]: ATP-binding lysine 
(a) and phosphorylation site (b); Nakamoto and Slayman [50]: phosphorylated intermediate sites (c); general nucleotide binding sequence in V, F type 
ATPase by Nelson and Taiz [51] (d); Serrano consensus region B with Asp residue forming phosphorylated intermediate [48] (e), and ecto-apyrase 19-83 
fragment [37] (f). Bold lettering indicates the possible phosphorylated intermediate sites of apyrase. The conserved amino acids in apyrase sequence with 
respect to the phosphorylation site sequences (b) and (c) are marked as follows: (*) identity, (+) similarity; similarity groups were defined as in Fig. 2. 
lent phosphorylated intermediate by Nakamoto and Slay- 
man ([50] and references cited therein). We have found 
that two similar fragments, YWYKGTTLN and NMSKT- 
GPAY, separated by 12 residues, are present in the Tyr50- 
Tyr80 stretch of the apyrase sequence. It is possible that 
both of them are involved in covalent bond formation with 
phosphates of ATP. This would be consistent with the 
experimental data showing the lack of ATP /ADP selectiv- 
ity and the lack of pyrophosphate r leased uring hydroly- 
sis [25,26,32]. The /3 and -/ phosphates might be bound to 
the above fragments and then hydrolyzed with the release 
of two orthophosphates. This again suggests a difference 
between ecto-apyrase and ATPases. The striking difference 
between them is the presence of two probable phospho- 
rylated intermediate sites. Some similarity to consensus 
region B was also detected for the 279-339 fragment of 
the apyrase sequence. 
Serrano Motif I, TGES, contains the active Glu residue 
involved in the hydrolysis of the phosphorylated intermedi- 
ate. It occurs in the larger consensus equence A, charac- 
terized by a high degree of similarity between P-type 
H+-ATPases [48]. There is no homologous fragment in rat 
'ecto-ATPase'. However, a similar NGES sequence was 
found in the 131-174 fragment corresponding to this 
consensus equence, and it is possible that it is responsible 
for the intermediate hydrolysis (Fig. 5). One cannot expect 
the similarity to be too high if in apyrase the hydrolysis 
occurs in two sites, corresponding to both pyrophosphates 
covalently bound to the enzyme molecule. This could be 
achieved by either a flexible loop with the possibility of 
conformational change triggered by the intermediate for- 
mation, or two fragments involved in the hydrolysis pro- 
(a) PGD IVE IAVGDKVPAD I RLT S I KST TLRVDQS I LTGESVSVI  K 
(b) PNVTGNNSNPMEGEP FVSLMCE PYTNNT SYLWSRNGE S L SEGDR 
(c) EGDRVT FSEGNRTLT LLNVRRTDKGYYECEARNPAT FNRS DP F 
Fig. 5. Alignment of the apyrase sequence with a H+-ATPase consensus 
region containing an active site for hydrolysis of the phosphorylated 
intermediate. Sequence match of Serrano Motif I [48] (a) with apyrase 
fragments 131-174 (b) and 171-213 (c). The ATPase active site residues 
involved in the hydrolysis are indicated by bold lettering. Top line 
indicates the similarity in a group of 12 structures of ATPases forming 
the phosphorylated intermediate as found by Serrano [48]: amino acids 
conserved in all 12 sequences marked by (*), amino acids conserved in 
all but two ATPases indicated by (+), while the residues conserved 
between all H+-ATPases are marked by (-). The groups of similar 
residues were defined as in Fig. 3. 
cess. In fact a fragment containing residues 171-213 
reveals some similarity to consensus region A, and might 
participate in the second intermediate hydrolysis. 
The sequence analysis seems to suggest he participa- 
tion of the 62-95, 159-213 and 279-339 fragments of 
apyrase in the binding of ATP adenine moiety and the 
hydrolysis process. However, weak sequence similarities 
to the consensus regions of P-ATPases indicate that apyrase 
cannot be a member of this enzymatic group. 
Valenzuela et al. [53] found that acetylation and nitra- 
tion of amino acids caused a loss of hydrolytic activity and 
changes in the 278 nm and 428 nm regions of the spec- 
trum. These results suggest he presence of tyrosine in the 
catalytic site. Incubation with 2,4,6-trinitrobenzenesulfonic 
acid or 2-hydroxy-5-nitrobenzyl bromide inactivated the 
enzyme, and in both cases the inhibition was prevented by 
ATP and ADP. These facts suggest he presence of amino 
groups and tryptophane in the catalytic center of apyrase. 
The above conclusions have been supported by the re- 
search on the ATP diphosphohydrolase from the rat pla- 
centa, showing that chemical modification of tyrosine and 
tryptophane residues, as well as the carboxylic groups, 
resulted in the partial inactivation of apyrase [54]. These 
results are in good agreement with our comparative se- 
quence analysis - we have identified the sequence frag- 
ments containing both these amino acids as those corre- 
sponding to active site fragments of ATPases. 
3.2. Comparison of  ecto-apyrases and other ecto-proteins 
The BLAST algorithm revealed a striking fact - more 
sequence similarity between apyrase and several protein 
tyrosine kinases and their receptors, than to ATPases. The 
probable reason for this similarity is that kinases have 
sequence fragments involved in the cleavage of ATP pyro- 
phosphate bonds or constituting the nucleotide binding 
site. If apyrase forms the phosphorylated intermediate, the 
functional sites could be similar to those of P-ATPases and 
kinases. Also high sequence similarity was found for the 
murine hepatitis virus (MHV) receptor from mice, biliary 
glycoprotein from mice [55] and a broad group of preg- 
nancy-specific glycoproteins from different sources. The 
similarities detected for apyrase and CAM, receptors and 
protein kinases suggest hat apyrases probably participate 
in a signal transmission and not in the ATP-dependent 
energetic processes as the ATPases do. 
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4. Catalytic mechanism 
Recognition of the catalytic mechanism is essential for 
understanding the metabolic role of apyrase. The products 
of hydrolysis performed by apyrases are AMP and or- 
thophosphate. Adenosine-5'-monophosphate as a product 
appears even in the very early stages of reaction, when 
there is a vast excess of ATP [32,35]. On the contrary, the 
hydrolysis catalyzed by ATPases stops at the ADP stage 
[3,56-58]. With the use of radio-labeled substrates and 
HPLC techniques, it was shown that the ratio of released 
orthopbosphate o AMP (Pa/AMP) equals two, while a 
similar ratio for ADP is close to one [32,35]. The rate of 
orthophosphate r lease seems to depend on the number of 
pyrophosphate bonds available in a single enzymatic ycle, 
and not on the substrate structure. This suggestion is 
confirmed by the apyrase capability of hydrolyzing thi- 
amine pyrophosphate [25]. It was also shown that pure 
apyrase preparations do not hydrolyze inorganic pyrophos- 
phate [8,25,26,29,31]. Therefore the organic part of the 
substrate seems to be necessary for the apyrase activity 
[251. 
There are two possible catalytic mechanisms for 
apyrase-catalyzed ATP hydrolysis, the single-stage reac- 
tion (Eq. (1)) or the two-stage hydrolysis with ADP as a 
by-product (Eqs. (2-3)): 
ATP + 2H20 ~ AMP + 2P i 
ATP + H20 ~ ADP + Pi 
ADP + H~O ~ AMP + P~ 
(l) 
(2) 
(3) 
Using ATP and ADP with radiolabeled /3 or y phos- 
phates, Tognoli and Mare [35] have shown that an equimo- 
lar amount of non-labeled ADP added to labeled ATP 
resulted in a decrease of/3- or y-labeled *Pi released from 
ATP by a half. This shows that in apyrase ADP competes 
with ATP for the same active site. Based on this result, 
Tognoli and Mare have proposed the subsequent mecha- 
nism of hydrolysis: 
of both substrates would significantly increase the overall 
hydrolysis rate. We have also shown that the /3 or 3' 
thiophosphate analogue of ATP decreased the hydrolysis 
rate of both ATP and ADP, while the thiophosphate ana- 
logue of ADP was only a weak apyrase inhibitor. There- 
fore, the apyrase affinity for ATP seems to be higher than 
that for ADP [32]. A vast excess of ATP will prevent he 
binding of the small amount of initially released ADP in 
the enzyme active site. 
Apyrase inactivated by a high temperature and gamma 
radiation revealed the same degree of inactivation for ATP 
and ADP hydrolysis [15,36,40]. It was also found that 
during the purification process the enzyme activity in- 
creases imilarly for both ATP and ADP [25,40,59,60] and 
the optimal pH for both substrates i almost identical [53]. 
Inhibitors, activators and chemical modifications of amino 
acids in the apyrase catalytic site also change the apyrase 
hydrolytic activity for ATP and ADP in a similar way 
[10-12,15,24,25,53,54]. These results fully support the 
mechanism presented as Eq. (4). 
5. Function of apyrases 
Based on the localization, solubility and some kinetic 
properties of apyrases from different sources, we propose 
the following classification of these enzymes. There is a 
soluble 'R' form, isolated from the cytosole of plant cells 
and insect saliva [10,14,29,40,65], and the membrane 'M'  
form [8-13,16-19,61-64]. Depending on the location of 
the catalytic site, both these forms can be divided into 
endo-apyrases ' I ' ( 'RI '  and 'MI ' )  with the catalytic site 
inside the cell [16,54,61-64,66], and ecto-apyrases 'O' 
( 'RO' and 'MO')  with the catalytic enter outside the cell 
[7-9,11,17,18,27,28,37,65,67-69]. Despite the location of 
these enzymes in organisms, their catalytic mechanism is
similar [10,12,25,31,32,40,65]. All apyrases eem to con- 
trol the concentration of energy-rich nucleotides and their 
lower energy hydrolysis products. In this chapter we will 
present results supporting this thesis. 
5.1. Funct ion o f  apyrases in the nervous system 
ATP + E ~- E-ADP ~ E-ADP ~ E + AMP + P~ (4) 
Pi 
The above mechanism is correct if hydrolysis is per- 
formed by a single and not two different phosphohydro- 
lases - ATPase and ADPase. The addition of 1 mM ADP 
to the optimal concentration ATP did not increase the 
release of orthophosphate from ATP [12,25,32,35]. There- 
fore the rate of hydrolysis did not depend on the concentra- 
tion of free ADP. This indicated that the substrates were 
hydrolyzed by the same enzyme. In the case where two 
different diphosphohydrolases were involved, the presence 
The participation of ATP in neurotransmission was 
initially postulated by Bumstock [5], based on the fact that 
the synaptic space contains not only pools of known 
neurotransmitters, but also pools of ATP. By exocytosis 
these pools migrate from cells into the synaptic space. 
Release of ATP causes the depolarization of a postsynaptic 
membrane and signal transmission to the adjacent neuron 
or neuro-muscle junction [5,12,20,70,71] (Fig. 6). There 
are two types of purinoceptors in animal cells. Pl receptors 
reveal low affinity for ATP/ADP and high affinity for 
adenosine and AMP. They are blocked by methylxantines. 
Their activation increases the cAMP concentration i the 
tissue [1,4,5,72,73]. P2 purinoceptors are characterized by 
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high affinity to ATP and ADP. They are inhibited by 
suramine, and ATP analogues are their agonists 
[1,20,71,74,75]. Adenosine and inosine, as well as small 
amounts of AMP and ADP are produced uring the rapid 
degradation of ATP in the synaptic space [2,5,12,18,20]. 
Two ecto-enzymes abundant in synaptic membranes, 
apyrase and 5'-nucleotidase [5,12,76], might be involved in 
this ATP degradation. Apyrase degrades ATP to AMP. 
Since AMP has a much smaller affinity for P2 receptors, 
the receptor itself is released and its stimulation is broken 
(Fig. 6) [1,5,18,20]. This indicates that in neurotransmis- 
sion, processes apyrases, by releasing a receptor, act simi- 
larly to acetylcholine esterases. ATPases cannot participate 
in this process because their basic hydrolysis product ADP 
also binds tightly to the P2 receptors [3,5,72]. 
5.2. Participation of apyrase in regulation of 5'-nucleo- 
tidase and adenylate cyclase actiui~, as well as in nu- 
cleotide recycling 
5'-nucleotidase, the enzyme abundant in the synaptic 
space, is inhibited by ADP and ATP, and activated by 
AMP (Fig. 7) [5,76]. By changing the [ATP + 
ADP]/[AMP] ratio, apyrase regulates the activity of this 
enzyme. The final product of reactions catalyzed by apyrase 
(Eq. 1) and subsequently 5'-nucleotidase (Eq. (5)) is 
adenosine which, contrary to AMP, penetrates the cell 
membranes and then can be phosphorylated, restoring the 
cellular ATP pool (Fig. 6) [5,8]. 
AMP + H20 ~ adenosine + Pi (5 )  
Adenosine ~ inosine + NH 3 (6) 
The fact that methylxantines block P1 receptors and 
inhibit adenylate cyclase suggests that the P~ receptor is 
linked to cyclase [1,5,21,77,78]. Adenosine stimulates the 
cyclase, causing the increase of cAMP concentration in the 
cell. Its further transformation into inosine is catalyzed by 
_J L 
Fig. 6. Nucleotide reaction pathway inside the synaptic space during the 
neurotransmission process. Hydrolysis of receptor-bound ATP, catalyzed 
by apyrase, releases the P2 receptor and AMP. 5'-nucleotidase further 
hydrolyze AMP-producing adenosine. Adenosine ither penetrates into 
the cell, where it is phosphorylated and restores the cellular ATP pool, or 
is degraded into inosine by adenine deaminase. Symbols used: P2, 
purinoceptor; APY, apyrase; 5' NUC, 5'-nucleotidase; ADE, adenosine; 
DAM, adenine deaminase; INO, inosine; LOV ATP, large opaque vesi- 
cles. 
VASODILATION 
ATP INHIBITION 
PLATELET r . . . . . . . . . . . . . . . . . .  \ -  
• ADP );APy--*AMP--S'Nuc~ 
AGGRE6ATION g 
ATP 
~'~ ~~VASOCONSTRICTION 
Fig. 7. Ecto-apyrase participation i the regulation of some enzymes and 
metabolic processes in the vascular system. Apyrase, by ADP degrada- 
tion, prevents blood platelet aggregation, simultaneously activating the 
5'-nucleotidase catalyzed conversion of AMP to adenosine. Adenosine 
binds to the P~ receptor, activates the adenylate cyclase and triggers the 
cAMP-related systems of platelet aggregation i hibition. Apyrase also 
degrades ATP bound to P2 receptors of endothelium cells and blood 
vessel smooth muscles, releases bound agonists and also affects the blood 
pressure. Symbols used: PI and P2, purinoceptors; APY, apyrase; 5'NUC, 
nucleotidase; ADE, adenosine; AC, adenylate cyclase; EDRF, endothe- 
lium-derived relaxing factor. 
deaminase (Eq. (6)) [5,79]. It is possible that the role of 
deaminase in releasing the P~ receptor is analogous to that 
of apyrase for the P2 receptor. 
The results discussed here suggest he possibility of 
cooperation between apyrase and 5'-nucleotidase. Such a 
cooperation would explain the observed presence of adeno- 
sine and inosine, and the lack of ADP or AMP in the 
synaptic space. This co-operation results in the release of 
receptors from agonist molecules and induces cAMP syn- 
thesis (Figs. 6 and 7) [10,79]. 
5.3. Participation in blood platelet aggregation 
In the extracellular space of the undamaged tissues, the 
ADP concentration is less than 0.1 /xM, and rises as 
damage processes [14]. ADP binds to P2 purine receptors 
on a platelet, causing blood platelet aggregation 
[1,14,21,80,81]. Ecto-apyrase abundant in mammalian en- 
dothelial cells and the smooth muscles of blood vessels, as 
well as in the saliva of many insects and ticks feeding on 
blood, controls the ADP-dependent platelet aggregation 
[ 1,14,21,65,69,81 ]. The anti-haemostatic role of apyrase is 
not limited to decreasing the ADP concentration. Equally 
important is the apyrase-controlled activation of 5'-nucleo- 
tidase, stimulated by AMP, also preventing blood platelet 
aggregation [21]. Concluding, apyrases prevent blood 
platelet aggregation directly, by decreasing the ADP con- 
centration, and indirectly, by increasing AMP concentra- 
tion. 
5.4. Role in blood pressure regulation 
Ecto-apyrases participate in the blood pressure regula- 
tion process. ATP binding to P2 receptors of the endothe- 
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lium cells of the vascular system results in the release of 
the endothelium-dependent r laxing factor (EDRF) (Fig. 
7). EDRF easily penetrates the cell membranes, causing 
the relaxation of the smooth muscles in the blood vessels 
and consequently lowering the blood pressure 
[1,14,21,36,82-84]. The latest research shows that the 
endothelium-derived r laxing factor in mammalian tissues 
is nitrogen oxide NO [21,83-85]. It penetrates the cell, 
activates the guanylate cyclase and increases the concen- 
tration of cGMP, which inhibits blood platelet aggregation 
independently from cAMP [21,84]. Apyrase hydrolyzes the 
agonist molecules bound to the receptor, releasing AMP 
from the receptor [14,18,20,36]. 
The effect of neural signal transmission to the vessels' 
smooth muscles is different. ATP binding to the P2 recep- 
tor of the neuro-muscle junction depolarizes the membrane 
and causes the contraction of the smooth muscles and 
higher blood pressure (Fig. 7). Apyrase, present on the cell 
surface, degrades ATP, releasing receptor and AMP. Then 
adenosine produced by 5'-nucleotidase stimulates the 
adenylate cyclase. The final increase of cAMP concentra- 
tion switches on the mechanisms lowering the blood pres- 
sure [14,21,82,83]. 
Summarizing, apyrase is one of the enzymes regulating 
the adenosine nucleotide level in the cell. A high value of 
the [ATP + ADP] to [AMP] concentration ratio is responsi- 
ble for effector stimulation in the nervous and vascular 
systems. The result is a contraction of blood vessels, 
stimulation of platelet aggregation and an increase of 
blood pressure. A decrease of this concentration ratio 
results in blood vessel relaxation and prevents the platelet 
aggregation. 
5.5. Regulation of  membrane permeability and transport of  
large molecules 
It was found that penetration of some proteins into the 
cell or cell nucleus is ATP-dependent and is apyrase-sensi- 
tive [23,86-89]. Proteins, and other substances of molecu- 
lar weight ranging from 1 to 150 kDa, penetrate into 
mouse fibroblast cells and human epidermal Langerhans 
cells in the presence of ATP [23,87]. The Langerhans cells, 
which contain large amounts of ecto-apyrase, are under 
normal circumstances very resistant to the large molecules' 
penetration. The penetration rate is not affected by the 
molecule size. The antibodies labeled with isothiocyanates 
penetrate into their cytoplasm in the presence of AMP-PNP, 
an ATP analogue not hydrolyzed by apyrase [23]. The 
membrane penetrat ion is st imulated by 5- 
p(fluorsulfonyl)benzoyl-adenosine (FSBA), blocking the 
ATP binding site of phosphohydrolases. It decreases in the 
presence of Ca 2÷ cations, which activate apyrases, but is 
increased by EDTA chelating the divalent cations. These 
results suggest hat by hydrolyzing ATP, apyrase prevents 
pore formation. 
5.6. Metabolic role of  endo-apyrases 
The role of endo-apyrase is less known than that of the 
enzymes bound to the external cell surface. One of the 
hypotheses i  that apyrases participate in sugar and glyco- 
protein metabolism. In some of these processes a vast 
amount of diphosphonucleotides is produced (Eq. (7)). By 
means of their degradation (Eq. (8)), apyrase enables a 
constant rate of polysaccharide synthesis [22,90,91]: 
XDP - S + A ¢~ S - A + XDP (7) 
XDP + H20 ~ XMP + Pi (8) 
where XDP is a diphosphonucleotide, S is sugar moiety 
and A is sugar or protein moiety. 
There is no direct evidence for apyrase participation i
these processes. However, there are some indicators of this 
participation. It is known that cell wall synthesis and 
protein glycosylation take place in the Golgi apparatus 
(GA) and endoplasmic reticulum (ER), and the presence of 
apyrase in both these structures was confirmed in rat 
mammary glands and wheat seedlings [16,64]. The cat- 
alytic center of the wheat enzyme is located on the extra- 
cytoplasmic surface of GA and ER membranes [16], mak- 
ing it available for reaction substrates. Also Fanta et al. 
[22] have shown that during 140 days of potato tuber 
growth, the amount of both starch and apyrase increases. 
According to Eq. (7), the increase of the amount of starch 
should be accompanied by an increased ADP concentra- 
tion. However, the experimental results are opposite to this 
conclusion. It was found that during potato tuber growth 
the adenylate cyclase activity is minimal, ADP concentra- 
tion decreases, and apyrase activity increases. The possible 
explanation is that endo-apyrase can, similarly to the en- 
zyme from blood vessels, lower the ADP level. 
6. Closing remarks 
The results presented in the previous chapters lead to 
the following conclusions: 
(1) The analysis of the primary structure, physico-chem- 
ical properties and metabolic function suggests that 
apyrases differ from all ATPases. The apyrases known so 
far are built up from a single polypeptide chain of a 
relatively low molecular weight. Their catalytic site is 
located on the extracytoplasmic surface of the membrane. 
They are not sensitive for the -SH reagents, and are not 
affected by typical ATPase inhibitors. Apyrases reveal ow 
substrate and ion specificity, catalyzing ATP and ADP 
degradation to AMP, and the K m values are similar for 
both these substrates. On the contrary, ATPases have a 
higher molecular weight, and consist of several subunits. 
Their catalytic site is located in cytoplasm, and their 
enzymatic activity is affected by the -SH group reagents. 
ATPases have a much higher affinity for ATP than ADP, 
and their main hydrolysis product is ADP. 
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The above differences are reflected in the primary 
structure of these two groups of enzymes. 
(2) The physiological role of apyrases eems to be the 
control of the nucleotide level in cells and tissues. Conse- 
quently, in a direct and indirect way they participate in the 
regulation of many physiological processes, including sig- 
nal transmission in the nervous system, blood platelet 
aggregation, blood pressure regulation and cell membrane 
permeability. This regulation takes place either on the 
PI/P2 purinoceptor  on an enzymatic level. 
(3) The apyrase participation in signal transmission 
processes and the similarity of the apyrase sequence to that 
of many cell receptors (CAM, MHVR, tyrosine kinase 
receptors) and protein kinases indicates that apyrases might 
participate not only in ATP and ADP level regulation, but 
also in signal modulation. This hypothesis i based on the 
results showing that the cells and organs containing these 
receptors also reveal a high level of ATP diphosphohydro- 
lase activity. 
(4) Since there are dramatic differences in the ATPases 
and apyrases function, the classification of apyrases as 
ATPases is incorrect. The proper name for these enzymes 
should be ATP diphosphohydrolases (apyrases). 
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